Journal
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Volume 297, Issue 5, Pages 1081-1088Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00404-018-4688-6
Keywords
Letrozole; Clomiphene citrate; Polycystic ovary syndrome; Randomized controlled trials; Meta-analysis
Categories
Funding
- National Natural Science Foundation of China [81671507]
- Fundamental Research Funds for the Central Universities (HUST) [2015ZDTD050]
- National Key Research and Development Program [2016YFC1000903]
Ask authors/readers for more resources
Polycystic ovary syndrome (PCOS) is a common endocrine disturbance affecting women in the reproductive age group. The present study aimed to compare the effects of letrozole (LE) and clomiphene citrate (CC) for ovulation induction in women with PCOS. The PUBMED, Web of Science, and EMBASE databases were screened systematically for randomized controlled trials (RCTs) published from database inception to July 2017. Eleven RCTs involving 2255 patients were included, and data were independently extracted and analyzed using 95% risk ratios (RRs) and confidence intervals (CIs) based on a random- or fixed-effect model (as appropriate). Meta-analyses of nine RCTs comparing LE and CC ovulation induction, followed by timed intercourse, indicated that the former significantly increased the ovulation rate (RR = 1.18; 95% CI 1.03-1.36, P = 0.01), pregnancy rate (RR = 1.34; 95% CI 1.09-1.64, P = 0.006), and live birth rate (RR = 1.55; 95% CI 1.28-1.88, P < 0.00001). However, LE and CC did not differ significantly in terms of the multiple pregnancy and abortion rates. Furthermore, LE for ovulation induction significantly improved the pregnancy rate after IUI. LE is superior to CC for ovulation induction in patients with PCOS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available